Navigation Links
SNM applauds US Department of Energy's move to develop domestic radioisotope supply
Date:1/27/2010

Reston, Va.SNM applauds a move by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help fund the development of a domestic supply of radioisotopes, which are used to help millions of patients each year through the diagnosis and staging of cancer, thyroid and heart disease.

Earlier this week, GE-Hitachi announced their selection by the NNSA to help develop a U.S. supply of Molybdenum-99 (Mo-99). Babcock & Wilcox (B&W) Technical Services Group also announced this week that it has been awarded approximately $9 million from the NNSA for the company's medical isotope production program. The company previously announced a partnership with Covidien to develop medical isotope production.

"We are pleased by this development," said Michael M. Graham, Ph.D., M.D., president of SNM. "The ongoing worldwide isotope shortage has long been a critical problem affecting the U.S. We are encouraged by the progress that has been made to date by the NNSA on this issue."

There are currently only five major producers of Molybdenum-99 (Mo-99) in the world, with none in the United States. Technetium-99the decay product ofMo-99 is a critical medical isotope used in more than 16 million diagnostic medical tests annually in the U.S. for the early detection of cancer, heart disease, thyroid disease and other serious conditions.

The current facilities that produce Mo-99 have experienced significant ongoing maintenance issues, which frequently cause these reactors to go offline, both for scheduled maintenance and unanticipated failures. These continuing problems were exacerbated when reactors were simultaneously down in Canada and the Netherlands earlier this year. Additionally, the Canadian government announced that it will no longer produce medical isotopes as of 2016, and the Netherlands reactor is scheduled to go offline in Feb. 2010 for four to six months. Starting in February, both reactors will be down at the same time.

The GE project aims to create a reliable U.S. supply of Mo-99 without the use of highly enriched uranium (HEU) to respond to a shortage from the repeated, unplanned outages at facilities where it is currently produced. They also say that their technology can be used with existing nuclear reactors rather than requiring the construction of new ones.

The B&W partnership would rely on building a new reactor using low-enriched uranium (LEU) to provide Mo-99, rather than HEU, which has been identified as a potential security threat. They are proposing to utilize a different reactor technology for production.

On a related matter, the American Medical Isotopes Production Act of 2009 (H.R. 3276), which was approved by the U.S. House of Representatives in November 2009, is now pending in the U.S. Senate. If passed, this legislation would provide critical funding to help create a stable and reliable supply of medical isotopes in the U.S.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Fairness Coalition Applauds Senate Passage of Mental Health Parity Bill
3. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
4. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
5. Coalition to Protect Floridas Drivers Applauds Governor Crist for Adding PIP to Special Session
6. AGD Applauds Congressional Support of SCHIP Reauthorization
7. Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking
8. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
9. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
10. California Alliance Applauds Governors Support of Group Home Reform for Foster Youth
11. ASGE Applauds News of Drop in Colorectal Cancer Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: